Cargando…

Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008–2016

BACKGROUND: Women with idiopathic pulmonary arterial hypertension (IPAH) have been found to have a worse haemodynamic status at diagnosis, but better survival than men. Over the past decade, demographics have changed and new treatments have become available. The objective of this study was to invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kjellström, Barbro, Nisell, Magnus, Kylhammar, David, Bartfay, Sven-Erik, Ivarsson, Bodil, Rådegran, Göran, Hjalmarsson, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689671/ https://www.ncbi.nlm.nih.gov/pubmed/31423450 http://dx.doi.org/10.1183/23120541.00075-2019

Ejemplares similares

Predicting mortality during long-term follow-up in pulmonary arterial hypertension
por: Kylhammar, David, et al.
Publicado: (2021)

Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment
por: Hjalmarsson, Clara, et al.
Publicado: (2021)

Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Kjellström, Barbro, et al.
Publicado: (2020)

Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2018)

Coping, social support and information in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A 2-year retrospective cohort study
por: Ivarsson, Bodil, et al.
Publicado: (2018)

Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2019)

Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
por: Kjellström, Barbro, et al.
Publicado: (2021)

Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
por: Kjellström, Barbro, et al.
Publicado: (2022)

Longitudinal changes in risk status in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2020)

Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy: a registry-based study
por: Hjalmarsson, Clara, et al.
Publicado: (2020)

The Odyssey from Symptom to Diagnosis of Pulmonary Hypertension from the Patients and Spouses Perspective
por: Ivarsson, Bodil, et al.
Publicado: (2021)

Outpatient specialist clinics for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the Nordic countries
por: Kjellström, Barbro, et al.
Publicado: (2020)

Prevalence of potential drug–drug interactions with disease‐specific treatments in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A registry study
por: Norell, Puck N., et al.
Publicado: (2022)

Novel Insight into How Nurses Working at PH Specialist Clinics in Sweden Perceive Their Work
por: Ivarsson, Bodil, et al.
Publicado: (2020)

Perceptions of Received Information, Social Support, and Coping in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2014)

Societal costs associated with pulmonary arterial hypertension: A study utilizing linked national registries
por: Runheim, Hannes, et al.
Publicado: (2023)

Societal costs associated to chronic thromboembolic pulmonary hypertension: A study utilizing linked national registries
por: Kjellström, Barbro, et al.
Publicado: (2023)

Atrioventricular plane displacement and regional function to predict outcome in pulmonary arterial hypertension
por: Lindholm, Anthony, et al.
Publicado: (2022)

Underfilling decreases left ventricular function in pulmonary arterial hypertension
por: Sjögren, Hannah, et al.
Publicado: (2021)

Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction
por: Sandqvist, Anna, et al.
Publicado: (2017)

Association between central haemodynamics and renal function in advanced heart failure: a nationwide study from Sweden
por: Bobbio, Emanuele, et al.
Publicado: (2022)

Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double‐Blind Controlled Trial
por: Lannemyr, Lukas, et al.
Publicado: (2018)

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
por: Bergh, Niklas, et al.
Publicado: (2020)

Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?
por: Kjellström, Barbro, et al.
Publicado: (2020)

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Hemodynamic Characteristics Including Pulmonary Hypertension at Rest and During Exercise Before and After Heart Transplantation
por: Lundgren, Jakob, et al.
Publicado: (2015)

Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2014)

The trajectory of renal function following mechanical circulatory support and subsequent heart transplantation
por: Bartfay, Sven‐Erik, et al.
Publicado: (2022)

Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2018)

Bone Mineral Density in Relation to Chronic Kidney Disease After Heart Transplantation: A Retrospective Single-center Study at Skåne University Hospital in Lund 1988–2016
por: Löfdahl, Eveline, et al.
Publicado: (2020)

Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
por: Ahmed, Abdulla, et al.
Publicado: (2021)

Sex differences in risk factors, treatment, and prognosis in acute stroke
por: Dahl, Solveig, et al.
Publicado: (2020)

Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2019)

Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2021)

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2019)

Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age—Where do we stand and what's next?
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experience
por: Bobbio, Emanuele, et al.
Publicado: (2022)

Doppler estimates of pulmonary vascular resistance to phenotype pulmonary hypertension in heart failure
por: Venkateshvaran, Ashwin, et al.
Publicado: (2019)

Elevated plasma WIF‐1 levels are associated with worse prognosis in heart failure with pulmonary hypertension
por: Kania, Kriss, et al.
Publicado: (2022)

Data on plasma tumour and metabolism related proteins’ potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension
por: Ahmed, Salaheldin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_avdt92cpqvhtnjmdk87sg07l2m